418 related articles for article (PubMed ID: 28533429)
1. The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.
Niu G; Franc A C; Zhang G; Roobsoong W; Nguitragool W; Wang X; Prachumsri J; Butler NS; Li J
J Biol Chem; 2017 Jul; 292(28):11960-11969. PubMed ID: 28533429
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.
Mathias DK; Jardim JG; Parish LA; Armistead JS; Trinh HV; Kumpitak C; Sattabongkot J; Dinglasan RR
Infect Genet Evol; 2014 Dec; 28():635-47. PubMed ID: 24929123
[TBL] [Abstract][Full Text] [Related]
3. Anopheles Midgut FREP1 Mediates Plasmodium Invasion.
Zhang G; Niu G; Franca CM; Dong Y; Wang X; Butler NS; Dimopoulos G; Li J
J Biol Chem; 2015 Jul; 290(27):16490-501. PubMed ID: 25991725
[TBL] [Abstract][Full Text] [Related]
4. Targeting mosquito FREP1 with a fungal metabolite blocks malaria transmission.
Niu G; Wang B; Zhang G; King JB; Cichewicz RH; Li J
Sci Rep; 2015 Oct; 5():14694. PubMed ID: 26437882
[TBL] [Abstract][Full Text] [Related]
5. Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship.
Lal AA; Patterson PS; Sacci JB; Vaughan JA; Paul C; Collins WE; Wirtz RA; Azad AF
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5228-33. PubMed ID: 11309510
[TBL] [Abstract][Full Text] [Related]
6. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
Mlambo G; Maciel J; Kumar N
Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
[TBL] [Abstract][Full Text] [Related]
7. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
[TBL] [Abstract][Full Text] [Related]
8. Targeting plasmodium α-tubulin-1 to block malaria transmission to mosquitoes.
Zhang G; Niu G; Hooker-Romera D; Shabani S; Ramelow J; Wang X; Butler NS; James AA; Li J
Front Cell Infect Microbiol; 2023; 13():1132647. PubMed ID: 37009496
[No Abstract] [Full Text] [Related]
9. CRISPR/Cas9 -mediated gene knockout of Anopheles gambiae FREP1 suppresses malaria parasite infection.
Dong Y; Simões ML; Marois E; Dimopoulos G
PLoS Pathog; 2018 Mar; 14(3):e1006898. PubMed ID: 29518156
[TBL] [Abstract][Full Text] [Related]
10. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
11. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.
Lavazec C; Boudin C; Lacroix R; Bonnet S; Diop A; Thiberge S; Boisson B; Tahar R; Bourgouin C
Infect Immun; 2007 Apr; 75(4):1635-42. PubMed ID: 17283100
[TBL] [Abstract][Full Text] [Related]
12. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Ramjanee S; Robertson JS; Franke-Fayard B; Sinha R; Waters AP; Janse CJ; Wu Y; Blagborough AM; Saul A; Sinden RE
Vaccine; 2007 Jan; 25(5):886-94. PubMed ID: 17049690
[TBL] [Abstract][Full Text] [Related]
13. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
14. Overview: immunology of malaria and progress in malaria vaccine development.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
[No Abstract] [Full Text] [Related]
15. Analysis of blood-induced Anopheles gambiae midgut proteins and sexual stage Plasmodium falciparum interaction reveals mosquito genes important for malaria transmission.
Cui Y; Niu G; Li VL; Wang X; Li J
Sci Rep; 2020 Aug; 10(1):14316. PubMed ID: 32868841
[TBL] [Abstract][Full Text] [Related]
16. Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions.
Da DF; Churcher TS; Yerbanga RS; Yaméogo B; Sangaré I; Ouedraogo JB; Sinden RE; Blagborough AM; Cohuet A
Exp Parasitol; 2015 Feb; 149():74-83. PubMed ID: 25541384
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.
Armistead JS; Morlais I; Mathias DK; Jardim JG; Joy J; Fridman A; Finnefrock AC; Bagchi A; Plebanski M; Scorpio DG; Churcher TS; Borg NA; Sattabongkot J; Dinglasan RR
Infect Immun; 2014 Feb; 82(2):818-29. PubMed ID: 24478095
[TBL] [Abstract][Full Text] [Related]
18. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
19. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
20. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
